Table 2.
Characteristic | PD−FOG | PD+FOG |
---|---|---|
N | 39 | 26 |
Age, y (mean±SD) | 69±8 | 67±12 |
Sex | ||
Female (N, %) | 18 (46) | 10 (38) |
Male (N, %) | 21 (54) | 16 (62) |
Education, y (mean±SD) | 16±2c | 16±2a |
Falling* | ||
0 falls (N, %) | 23 (60) | 8 (31) |
1 fall (N, %) | 8 (20) | 2 (8) |
≥1 fall (N, %) | 16 (40) | 18 (69) |
≥2 falls (N, %) | 8 (20) | 16 (61) |
Cognitive domain | ||
MoCA (/30; mean±SD) | 26.1±2.7 | 25.4±2.6 |
Set shifting | ||
Trailmaking A (s; median±IQR)* | 29.8±11.0 | 41.1±16.3a |
Trailmaking B (s; median±IQR)* | 65.5±54.7 | 113.1±88.6a |
Trailmaking B–A (s; median±IQR)* | 34.3±44.2 | 69.8±71.6a |
Motor domain | ||
Berg Balance Scale (/54; mean±SD)* | 52.9±3.3 | 49.2±6.0 |
Gait speed, m/s (mean±SD) | 1.06±0.21 | 0.95±0.26b |
Clinical characteristics | ||
PD duration, y (mean±S D) | 6.4±5.8 | 8.5±5.1a |
UPDRS-III (/108; mean±SD)* | 29.4±7.8 | 35.9±13.0 |
Freezing of Gait | ||
Freezer (N, %) | 0 (0) | 26 (100) |
Nonfreezer (N, %) | 39 (100) | 0 (0) |
Hoehn & Yahr stage | ||
3 (N, %) | 9 (23) | 11 (42) |
2.5 (N, %) | 6 (15) | 6 (23) |
2 (N, %) | 17 (43) | 9 (35) |
1.5 (N, %) | 6 (15) | 0 (0) |
1 (N, %) | 1 (3) | 0 (0) |
Abbreviations: PD, Parkinson’s disease; MoCA, Montreal Cognitive Assessment.
P<0.05, derived from tests of central tendency or homogeneity comparing PD+FOG and PD−FOG groups.
N=25.
N=24.
N=38.